Edition:
United Kingdom

Trevena Inc (TRVN.OQ)

TRVN.OQ on NASDAQ Stock Exchange Global Select Market

0.85USD
15 Oct 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.85
Open
$0.89
Day's High
$0.91
Day's Low
$0.83
Volume
967,198
Avg. Vol
488,291
52-wk High
$3.58
52-wk Low
$0.76

Select another date:

Thu, Oct 11 2018

UPDATE 2-Trevena's opioid painkiller fails to get FDA panel backing

Oct 11 Trevena Inc's opioid injection for managing acute pain failed to win the backing of an advisory panel to the Food and Drug Administration on Thursday, against the backdrop of opioid addiction in the United States reaching epidemic proportion.

Trevena's opioid painkiller fails to get FDA panel nod

Oct 11 An advisory panel to the U.S. Food and Drug Administration on Thursday voted against approval of Trevena Inc's opioid injection for managing acute pain.

FDA staff raises safety issues over Trevena opioid injection

Trevena Inc's opioid injection to treat acute pain could be abused and potentially lead to overdose, staff reviewers of the U.S. Food and Drug Administration said on Tuesday, sending the drugmaker's shares down 66 percent.

UPDATE 1-FDA staff raises safety issues over Trevena opioid injection

Oct 9 Trevena Inc's opioid injection to treat acute pain could be abused and potentially lead to overdose, staff reviewers of the U.S. Food and Drug Administration said on Tuesday, sending the drugmaker's shares down 66 percent.

FDA staff raises safety concerns over Trevena opioid drug

Oct 9 Staff reviewers of the U.S. Food and Drug Administration on Tuesday raised safety concerns over Trevena Inc's opioid injection to treat acute pain, saying the treatment has an abuse and overdose potential.

BRIEF-Trevena Q1 Loss Per Share $0.14

* Q1 EARNINGS PER SHARE VIEW $-0.22 -- THOMSON REUTERS I/B/E/S

BRIEF-Trevena Inc And Jiangsu Nhwa Pharmaceutical Announce License Agreement For Oliceridine In China

* TREVENA INC. AND JIANGSU NHWA PHARMACEUTICAL CO. LTD ANNOUNCE LICENSE AGREEMENT FOR OLICERIDINE IN CHINA

Select another date: